Research ArticleOriginal Article
Open Access

L-carnitine reduces acute lung injury in experimental biliary obstruction

Ozgur Kaya, Yavuz S. Koca, Ibrahim Barut, Sirin Baspinar and Mehmet Z. Sabuncuoglu
Saudi Medical Journal September 2015, 36 (9) 1046-1052; DOI: https://doi.org/10.15537/smj.2015.9.12206

References

  1. ↵
    1. Su CH,
    2. P’eng FK,
    3. Lui WY
    (1992) Factors affecting morbidity and mortality in biliary tract surgery. World J Surg 16:536–540.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Assimakopoulos SF,
    2. Vagianos CE
    (2009) Bile duct ligation in rats: a reliable model of hepatorenal syndrome? World J Gastroenterol 15:121.
    OpenUrlPubMed
  3. ↵
    1. Papakostas C,
    2. Bezirtzoglou E,
    3. Pitiakoudis M,
    4. Polychronidis A,
    5. Simopoulos C
    (2003) Endotoxinemia in the portal and the systemic circulation in obstructive jaundice. Clin Exp Med 3:124–128.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Sakrak O,
    2. Akpinar M,
    3. Bedirli A,
    4. Akyurek N,
    5. Aritas Y
    (2003) Short and long-term effects of bacterial translocation due to obstructive jaundice on liver damage. Hepatogastroenterology 50:1542–1546.
    OpenUrlPubMed
  5. ↵
    1. Kucuk C,
    2. Ok E,
    3. Yilmaz Z,
    4. Sozuer E,
    5. Muhtaroglu S,
    6. Arar M
    (2003) The effects of dimethylsulfoxide in experimental obstructive jaundice. Acta Chir Belg 103:392–395.
    OpenUrlPubMed
  6. ↵
    1. Ogetman Z,
    2. Dirlik M,
    3. Caglikulekci M,
    4. Canbaz H,
    5. Karabacak T,
    6. Yaylak F,
    7. et al.
    (2006) The effect of aminoguanidine on blood and tissue lipid peroxidation in jaundiced rats with endotoxemia induced with LPS. J Invest Surg 19:19–30.
    OpenUrlPubMed
  7. ↵
    1. Cooke MS,
    2. Evans MD,
    3. Dizdaroglu M,
    4. Lunec J
    (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Akca T,
    2. Canbaz H,
    3. Tataroglu C,
    4. Caglikulekci M,
    5. Tamer L,
    6. Colak T,
    7. et al.
    (2005) The effect of N-acetylcysteine on pulmonary lipid peroxidation and tissue damage. J Surg Res 129:38–45.
    OpenUrlPubMed
  9. ↵
    1. Barut I,
    2. Kaya S
    (2014) The diagnostic value of C-reactive protein in bacterial translocation in experimental biliary obstruction. Adv Clin Exp Med 23:197–203.
    OpenUrl
  10. ↵
    1. Wilson AD,
    2. Hart A,
    3. Wiberg M,
    4. Terenghi G
    (2010) Acetyl-l-carnitine increases nerve regeneration and target organ reinnervation - a morphological study. J Plast Reconstr Aesthet Surg 63:1186–1195.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Buege JA,
    2. Aust SD
    (1978) Microsomal lipid peroxidation. Methods Enzymol 12:302–310.
    OpenUrl
  12. ↵
    1. Theodorus P,
    2. Akerboom M,
    3. Sies H
    (1981) Assay of glutathione, glutathione disulfide and glutathione mixed disulfides in biological samples. Methods Enzymol 77:373–383.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Bergmeyer HU
    1. Luck H
    (1971) in Methods in enzymatic analysis, Catalase, ed Bergmeyer HU (Academic Press, New York (NY)), p 885.
  14. ↵
    1. Minami M,
    2. Yoshikawa H
    (1979) A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta 92:337–342.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Warren JS,
    2. Yabroff KR,
    3. Remick DG,
    4. Kunkel SL,
    5. Chensue SW,
    6. Kunkel RG,
    7. et al.
    (1989) Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 84:1873.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Ozdulger A,
    2. Cinel I,
    3. Koksel O,
    4. Cinel L,
    5. Avlan D,
    6. Unlu A,
    7. et al.
    (2003) The protective effect of N-Acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 19:336–372.
    OpenUrl
  17. ↵
    1. Jiang WG,
    2. Puntis MC,
    3. Hallett MB
    (1994) Neutrophil priming by cytokines in patients with obstructive jaundice. HPB Surg 7:281–289.
    OpenUrlPubMed
  18. ↵
    1. Yildiz H,
    2. Coskuner I,
    3. Bulbuloglu E,
    4. Silay E,
    5. Kurutas EB,
    6. Dogan Z,
    7. et al.
    (2012) The protective effects of ketamine and propofol in obstructive jaundice: an experimental study. Bratisl Lek Listy 113:139–144.
    OpenUrlPubMed
  19. ↵
    1. Hatipoğlu AR,
    2. Oğuz S,
    3. Gürcan S,
    4. Yalta T,
    5. Albayrak D,
    6. Erenoğlu C,
    7. et al.
    (2013) Combined effects of tauroursodeoxycholic Acid and glutamine on bacterial translocation in obstructive jaundiced rats. Balkan Med J 30:362–368.
    OpenUrl
  20. ↵
    1. White JS,
    2. Hoper M,
    3. Parks RW,
    4. Clements WD,
    5. Diamond T
    (2006) Patterns of bacterial translocation in experimental biliary obstruction. J Surg Res 132:80–84.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Kolodziejczyk J,
    2. Saluk-Juszczak J,
    3. Wachowicz B
    (2011) L-carnitine protects plasma components against oxidative alterations. Nutrition 27:693–699.
    OpenUrlPubMed
  22. ↵
    1. Mingorance C,
    2. Rodrıguez-Rodrıguez R,
    3. Justo ML,
    4. Alvarez de Sotomayor M,
    5. Herrera MD
    (2011) Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders. Vasc Health Risk Manag 7:169–176.
    OpenUrlPubMed
  23. ↵
    1. Augustyniak A,
    2. Skrzydlewska E
    (2010) The influence of L-carnitine supplementation on the antioxidative abilities of serum and the central nervous system of ethanol-induced rats. Metab Brain Dis 25:381–389.
    OpenUrlPubMed
  24. ↵
    1. Miguel-Carrasco JL,
    2. Monserrat MT,
    3. Mate A,
    4. Vazquez CM
    (2010) Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats. Eur J Pharmacol 632:65–72.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Badger SA,
    2. Jones C,
    3. McCaigue M,
    4. Clements BW,
    5. Parks RW,
    6. Diamond T,
    7. et al.
    (2012) Cytokine response to portal endotoxaemia and neutrophil stimulation in obstructive jaundice. Eur J Gastroenterol Hepatol 24:25–32.
    OpenUrlPubMed
  26. ↵
    1. Dirlik M,
    2. Karahan A,
    3. Canbaz H,
    4. Caglikulekci M,
    5. Polat A,
    6. Tamer L,
    7. et al.
    (2009) Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopoly-saccharide-induced sepsis. Curr Ther Res 70:299–315.
    OpenUrl
  27. ↵
    1. van der Veen BS,
    2. de Winther MP,
    3. Heeringa P
    (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11:2899–2937.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Adam M,
    2. Gajdova S,
    3. Kolarova H,
    4. Kubala L,
    5. Lau D,
    6. Geisler A,
    7. et al.
    (2014) Red blood cells serve as intravascular carriers of myeloperoxidase. J Mol Cell Cardiol 74:353–363.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Ramage L,
    2. Proudfoot L,
    3. Guy K
    (2004) Expression of C-reactive protein in human lungepithelial cells and upregulation by cytokines and carbon particles. Inhal Toxicol 16:607–613.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    1. Rahman I,
    2. MacNee W
    (2000) Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16:534–554.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section